ADVANCED TRIPLE NEGATIVE BREAST CANCER
Clinical trials for ADVANCED TRIPLE NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TRIPLE NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED TRIPLE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough breast cancer: experimental drug trial seeks to slow disease
Disease control Not yet recruitingThis study is testing whether the drug sacituzumab govitecan can slow cancer progression when used as the first treatment for adults with advanced triple-negative breast cancer. Researchers will give the drug to 24 participants and track how well their cancer responds, comparing …
Matched conditions: ADVANCED TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Nathalie Levasseur • Aim: Disease control
Last updated Apr 04, 2026 03:50 UTC
-
Common drug tested to tame Chemo's harsh side effect
Symptom relief Not yet recruitingThis study aims to see if giving atropine, a common medication, before chemotherapy can prevent severe diarrhea in patients with advanced breast cancer. It will involve about 30 patients who are receiving a specific chemotherapy drug called sacituzumab govitecan. The main goal is…
Matched conditions: ADVANCED TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: MedSIR • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New home care program aims to ease suffering for seriously ill patients
Symptom relief Not yet recruitingThis study is testing a new way to deliver palliative care at home for people with advanced heart failure or certain cancers. The program adjusts the level of support a patient receives based on how their symptoms and daily function change over time. It aims to improve quality of…
Matched conditions: ADVANCED TRIPLE NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC